Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Orthosteric and allosteric action of the C5a receptor antagonists

Journal Article · · Nature Structural & Molecular Biology

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
FOREIGN
OSTI ID:
1502204
Journal Information:
Nature Structural & Molecular Biology, Vol. 25, Issue 6; ISSN 1545-9993
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
ENGLISH

References (66)

International Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors January 2013
Protein structure and dynamics studied by mass spectrometry: H/D exchange, hydroxyl radical labeling, and related approaches August 2008
Role of the carboxyl terminal di-leucine in phosphorylation and internalization of C5a receptor June 2008
Crystallizing Membrane Proteins for Structure Determination: Use of Lipidic Mesophases June 2009
Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine January 2015
High-resolution crystal structure of human protease-activated receptor 1 December 2012
Comparative Agonist/Antagonist Responses in Mutant Human C5a Receptors Define the Ligand Binding Site January 2005
Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. February 1994
Potent Cyclic Antagonists of the Complement C5a Receptor on Human Polymorphonuclear Leukocytes. Relationships between Structures and Activity March 2004
Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40 June 2017
Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief November 2014
MolProbity: More and better reference data for improved all-atom structure validation: PROTEIN SCIENCE.ORG November 2017
Inhibiting the C5–C5a receptor axis August 2011
Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727 January 2018
C5a-Stimulated Recruitment of  -Arrestin2 to the Nonsignaling 7-Transmembrane Decoy Receptor C5L2 July 2009
Structural basis for selectivity and diversity in angiotensin II receptors April 2017
Fusion Partner Toolchest for the Stabilization and Crystallization of G Protein-Coupled Receptors June 2012
Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche May 2014
Structure of the agonist-bound neurotensin receptor October 2012
Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions July 2012
Formyl peptide receptor-mediated ERK1/2 activation occurs through Gi and is not dependent on β-arrestin1/2 February 2008
Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease January 2011
Molecular Characterization of the Gerbil C5a Receptor and Identification of a Transmembrane Domain V Amino Acid That Is Crucial for Small Molecule Antagonist Interaction October 2005
Function, structure and therapeutic potential of complement C5a receptors October 2007
Discovery of an irreversible HCV NS5B polymerase inhibitor December 2013
Activation mechanism of endothelin ETB receptor by endothelin-1 September 2016
The role of the anaphylatoxins in health and disease September 2009
An Activation Switch in the Ligand Binding Pocket of the C5a Receptor November 2000
Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer’s disease August 2015
Pivotal Advance: Interconversion between pure chemotactic ligands and chemoattractant/secretagogue ligands of neutrophil C5a receptor by a single amino acid substitution January 2010
Identification of a Potent and Orally Active Non-peptide C5a Receptor Antagonist October 2002
Structural Basis for Apelin Control of the Human Apelin Receptor June 2017
Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse September 2006
Structure of a nanobody-stabilized active state of the β2 adrenoceptor January 2011
Modulation of the antitumor immune response by complement September 2008
Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study October 2016
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists October 2010
MolProbity : all-atom structure validation for macromolecular crystallography December 2009
Two disparate ligand-binding sites in the human P2Y1 receptor March 2015
Coot model-building tools for molecular graphics November 2004
Role of c5a in Inflammatory Responses April 2005
C5a and pain development: An old molecule, a new target October 2016
Crystal structure of the β2 adrenergic receptor–Gs protein complex July 2011
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis April 2017
Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease February 2017
Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors May 2009
Effective Application of Bicelles for Conformational Analysis of G Protein-Coupled Receptors by Hydrogen/Deuterium Exchange Mass Spectrometry March 2015
PHENIX: a comprehensive Python-based system for macromolecular structure solution January 2010
Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5a June 1999
Mapping the Ligand-Binding Site on the C5a Receptor:  Arginine 74 of C5a Contacts Aspartate 282 of the C5a Receptor November 2001
Rapid Context-Dependent Ligand Desolvation in Molecular Docking August 2010
Constitutive Activation and Endocytosis of the Complement Factor 5a Receptor: Evidence for Multiple Activated Conformations of a G Protein-Coupled Receptor December 2002
Molecular control of δ-opioid receptor signalling January 2014
C5a Receptor Activation: GENETIC IDENTIFICATION OF CRITICAL RESIDUES IN FOUR TRANSMEMBRANE HELICES May 1999
Biologically Active Conformer of the Effector Region of Human C5a and Modulatory Effects of N-Terminal Receptor Binding Determinants on Activity March 1997
Recent developments in low molecular weight complement inhibitors December 2009
Structural insights into µ-opioid receptor activation August 2015
Identification and Characterization of NDT 9513727 [ N , N -bis(1,3-Benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1 H -imidazole-5-methanamine], a Novel, Orally Bioavailable C5a Receptor Inverse Agonist August 2008
Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88) January 2013
Modeling Molecular Mechanisms of Binding of the Anaphylatoxin C5a to the C5a Receptor March 2008
Identification of Phosphorylation Codes for Arrestin Recruitment by G Protein-Coupled Receptors July 2017
C5L2: a controversial receptor of complement anaphylatoxin, C5a March 2013
[20] Processing of X-ray diffraction data collected in oscillation mode January 1997
C5a Receptor Oligomerization: I. DISULFIDE TRAPPING REVEALS OLIGOMERS AND POTENTIAL CONTACT SURFACES IN A G PROTEIN-COUPLED RECEPTOR June 2003
Immunological effects and therapeutic role of C5a in cancer November 2014
Phaser crystallographic software July 2007

Related Subjects